Gene Therapy To Treat Inherent Blindness Will Cost $850,000: Is This The Future Of Medicine? Luxturna, a drug for gene therapy to cure inherent blindness that was recently approved by the FDA, will cost $850,000. Does the prohibitive cost outweigh the advantages of a one-time treatment to cure a hereditary disease? by Aaron Mamiit